Skip to main content
. 2018 Jun 29;1(2):e180482. doi: 10.1001/jamanetworkopen.2018.0482

Table 4. Multivariable Regression Model of Cumulative Repository Corticotropin–Related Payments (Scaled to $10 000) and Log-Transformed Medicare Spending on Corticotropin.

Variable Coefficient (95% CI) P Value
Payment amounta 1.0787 (1.0435-1.1152) <.001
Specialty
Nephrology 1 [Reference] <.001
Neurology 0.9600 (0.7721-1.1936)
Rheumatology 1.4378 (1.2223-1.6913)
Female 0.8554 (0.7422-0.9858) .03
Practice size
1 1 [Reference] .31
2-10 1.1082 (0.9225-1.3314)
11-50 0.9220 (0.7438-1.1429)
>50 1.0645 (0.8871-1.2773)
Time since graduation, y
≤10 1 [Reference] .49
11-30 1.1773 (0.8781-1.5786)
>30 1.1906 (0.8744-1.6212)
Not reported 1.4069 (0.9091-2.1772)
Region
Northeast 1 [Reference] .35
Midwest 0.9585 (0.7814-1.1756)
South 0.9045 (0.762-1.0736)
Pacific West 1.0532 (0.8356-1.3275)
Mountain West 0.8003 (0.596-1.0748)
Total noncorticotropin payments from industrya 0.9972 (0.9999-1.0003) .16
No. of noncorticotropin prescriptions per beneficiary 1.0060 (0.9901-1.0221) .46
Cost of noncorticotropin prescriptions per claim 1.0001 (0.9934-1.0011) .40
a

Scaled to $10 000.